MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

In the areas held by the Sudanese government, attacks by bandits/militias on MSF and other relief agencies have intensified in frequency and brutality.

More >

In a recent study, MSF and its research affiliate, Epicentre, showed how rapid, mass vaccinations can reduce the toll inflicted by measles epidemics in Africa. "The fact that the WHO does not promote vaccination campaigns during an epidemic only hinders an effective emergency response," said epidemiologist Rebecca Grais.

More >

Preliminary results from a study conducted by Doctors Without Borders(MSF) show that significantly shorter and simplified treatment of African sleeping sickness could be possible in the near future.

More >

With approximately 9 million people developing active tuberculosis (TB) every year and 1.7 million deaths annually, TB is far from under control. Human immunodeficiency virus (HIV) infection dramatically increases the risk of developing active tuberculosis and is driving the TB epidemic in Africa.

More >

Tuberculosis (TB) remains the leading cause of death from a curable infectious disease, despite the availability of short-course therapy that can be both inexpensive and effective.

More >

The purpose of this document is to provide information on prices and suppliers that will help purchasers make informed decisions when buying antiretrovirals (ARVs). This report is a pricing guide and does not include detailed information about the quality of the products listed.

More >

Canada was the first G8 country to amend its national laws to implement the World Trade Organization’s August 30th decision, allowing generic versions of patented drugs to be manufactured and exported under compulsory license.

More >

In the past 5 years, considerable progress has been made in scaling-up access to antiretroviral therapy.  Today, 1.3 million people are receiving treatment.  But a huge amount remains to be done.

More >

Pages